AJP - Heart  AJP: Regulatory, Integrative and Comparative Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 276: H1780-H1787, 1999;
0363-6135/99 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, S.-J.
Right arrow Articles by Vatner, S. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, S.-J.
Right arrow Articles by Vatner, S. F.
Vol. 276, Issue 5, H1780-H1787, May 1999

An alpha -cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes

Song-Jung Kim1, Kenji Iizuka1, Ralph A. Kelly2, Yong-Jian Geng1, Sanford P. Bishop1, Guiping Yang1, Amelia Kudej1, Bradley K. McConnell3, Christine E. Seidman4, Jonathan G. Seidman3, and Stephen F. Vatner1

1 Cardiovascular and Pulmonary Research Institute, Allegheny University of the Health Sciences, Pittsburgh, Pennsylvania 15212; 3 Department of Genetics, Harvard Medical School and Howard Hughes Medical Institute, Boston; 2 Cardiology Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston; and 4 Howard Hughes Medical Institute, Boston, Massachusetts 02115


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Left Ventricular (LV) myocytes were isolated from 15-wk-old male mice bearing the Arg403 right-arrow Gln alpha -cardiac myosin heavy chain missense mutation (alpha -MHC403/+), a model of familial hypertrophic cardiomyopathy. LV myocytes were classified morphologically: type I, rod shaped with parallel myofibrils; type II, irregularly shaped, shorter and wider than wild-type (WT) control cells, with parallel myofibrils; and type III, irregularly shaped with disoriented myofibrils. Compared with WT myocytes, alpha -MHC403/+ myocytes had fewer type I cells (WT = 74 ± 3%, alpha -MHC403/+ = 41 ± 4%, P < 0.01) and more type III cells (WT= 12 ± 3%, alpha -MHC403/+ = 49 ± 7%, P < 0.01). In situ histology also demonstrated marked myofibrillar disarray in the alpha -MHC403/+ hearts. With the use of video edge detection, myocytes were paced at 1 Hz (37°C) to determine the effects of the mutation on myocyte function. End-diastolic length was reduced in mutant myocytes, but fractional shortening (% contraction) and sarcomere length were not. Velocity of contraction (-dL/dtmax) was depressed in mutant cells, but more in type II and III cells (-31%) than in type I cells (-18%). Velocity of relaxation (+dL/dt) was also depressed more in type II and III cells (-38%) than in type I cells (-16%). Using fura 2 dye with intracellular Ca2+ transients, we demonstrated that in alpha -MHC403/+ myocytes, the amplitude of the Ca2+ signal during contraction was unchanged but that the time required for decay of the signal to decrease 70% from its maximum was delayed significantly (WT = 159 ± 8 ms; alpha -MHC403/+ = 217 ± 14 ms, P < 0.01). Sarco(endo)plasmic reticulum Ca2+-ATPase mRNA levels in alpha -MHC403/+ and WT mice were similar. These data indicate that the altered cardiac dysfunction of alpha -MHC403/+ myocytes is directly due to defective myocyte function rather than to secondary changes in global cardiac function and/or loading conditions.

transgenic mice; calcium


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

ALTHOUGH MOST CARDIAC HYPERTROPHY occurs as a secondary response to hemodynamic overload or other mechanical factors, hypertrophy can also be induced by inherited mutations (28). A number of different missense mutations in the head and head/rod region of the beta -cardiac myosin heavy chain (MHC) gene can cause familial hypertrophic cardiomyopathy (FHC) (7, 8, 10, 24). One of these mutations, Arg403 right-arrow Gln has nearly 100% penetrance and dramatically reduces the life expectancy of affected individuals (8). However, the mechanism by which the Arg403 right-arrow Gln mutation and other mutations in sarcomere protein genes cause cardiac hypertrophy and sudden death is not certain.

To further understand the physiological and pathological mechanisms by which the Arg403 right-arrow Gln missense mutation causes FHC, a murine model was created by introducing this missense mutation into the alpha -cardiac MHC gene (9). Heterozygous mice bearing the Arg403 right-arrowGln missense mutation (designated alpha -MHC403/+) exhibit alterations in cardiac function and histopathology characteristic of human FHC, homologous to human beta -cardiac MHC, with 92% identity overall (9). The alpha -MHC403/+ mouse hearts exhibit lower cardiac output and abnormal left ventricular (LV) relaxation, and they also demonstrate fibrosis. Whether the alteration in cardiac function of mutant hearts is directly due to defective myocyte function or whether these differences in function are secondary to changes in cardiac structure and/or loading conditions remains uncertain.

To address this question, we have studied the structure and function of isolated cardiac myocytes bearing the Arg403 right-arrow Gln mutation from left ventricles of alpha -MHC403/+ mice. We examined the morphology of the myocytes and observed that many of the mutant myocytes were shorter and wider than wild-type (WT) myocytes, with irregular cellular borders and myofibrillar disarray. We measured contractile and relaxation properties by means of computer-assisted video motion edge detection. Measuring these indexes from single cardiac myocytes provides intrinsic contractile and relaxation function, independent of the extracellular matrix and systemic hemodynamic and neurohormonal effects. After we determined that myocyte relaxation was delayed and accompanied by delayed recovery of Ca2+ transients, we measured the message for sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) to see whether it was altered in the mutant.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Heterozygous alpha -MHC403/+ mice were bred by mating alpha -MHC403/+ mice as described previously (9). WT mice were the littermates of alpha -MHC403/+ mice.

Preparation of mouse ventricular myocytes. Cardiac myocytes were prepared from 15-wk-old male wild-type (n = 17) and alpha -MHC403/+ mice (n = 19). In brief, the heart was rapidly excised and submerged in Ca2+-free Tyrode solution containing (in mM) 140 NaCl, 5.4 KCl, 1 MgCl2, 0.33 NaH2PO4, 10 glucose, and 5 HEPES at pH 7.4. The aorta was cannulated with a blunt-tip needle (20 gauge) on a perfusion apparatus. The heart was perfused for 3 min with Tyrode solution and was then perfused with Tyrode solution with 2% calf serum (Sigma) and 75 U/ml each of collagenase types 1 and 2 (Worthington). Perfusion pressure was monitored continuously through an in-line pressure transducer during digestion. Perfused LV free walls were excised when perfusion pressure reached ~20-30 mmHg from an initial pressure of 60-70 mmHg, which provided a consistent quality of myocytes (>50% yield). Perfusion was identical for both groups. The digested tissue was then placed in the separate petri dish filled with Tyrode solution with 2% calf serum and 10% bovine albumin (fraction V, Sigma). All perfused media were maintained at 37°C, and all solutions were continuously bubbled with 95% O2-5% CO2. After the tissue was minced and gently aspirated, the cells were teased apart to disperse myocytes, and the myocyte-containing solution was placed in a tube to allow viable myocytes to settle by gravity. Myocytes were stored at room temperature before use, and the protocol was completed within 3 h after isolation to avoid any deterioration due to prolonged storage of cells.

Measurement of contractile performance. Myocytes were transferred to a warmed (37°C) and continuously perfused cell chamber located on the stage of an inverted microscope (Nikon). The chamber was perfused with physiological buffer containing (in mM) 120 NaCl, 2.6 KCl, 1.2 MgCl2, 1.2 KH2PO4, 11 glucose, 5 HEPES, 25 NaHCO3, 2 taurine, 1 pyruvate, and 1 Ca2+. Myocyte contraction was induced once per second (1 Hz) by platinum field electrodes placed in the cell chamber that were attached to a stimulator (Grass S48, Grass Instruments). Cell images were continuously acquired through a ×40 objective lens (Nikon) and transmitted to a 240 sample/s charge-coupled device (CCD) video camera (TM-640, Pulnix). The output from the CCD camera was displayed on a video monitor (PVM-135, Sony). Myocytes were selected for study according to the following criteria (6): a rod-shaped appearance with clear striations and no membrane blebs, no spontaneous contractions when unstimulated in 1 mM Ca2+, and steady diastolic length and contractile amplitude at basal stimulation rates. Myocyte length was measured using a video motion edge detector (VED103, Crescent Electronics), and the data were acquired at 240 samples/s, stored, and analyzed on a Dell 433 computer. Myocyte dimensions were calibrated with a hemacytometer grid placed on the microscope stage.

Measurement of myocyte transient Ca2+ concentration. LV myocytes from 9 alpha -MHC403/+ and 10 WT mice were loaded with 3.8 mM of fura 2-AM (Sigma) dissolved in dimethyl sulfoxide at room temperature (20°C) for 30 min in Tyrode solution with 2% calf serum and 10% bovine albumin (fraction V, Sigma). After cells were loaded, they were washed with Tyrode solution for 30 min and placed in the myocyte perfusion chamber on the microscope, as described in Measurement of contractile performance. The myocytes were excited by ultraviolet light (wavelengths 340 and 380 nm, alternately) and the fura emission wavelength (510 nm) was synchronously monitored by the Photoscan dual-beam spectrofluorophotometer (Photon Technology). Intracellular free Ca2+ was measured as the fluorescence ratio (340/380) because high mitochondrial fluorescence affects calculated Ca2+ concentration in fura 2-loaded myocytes, and the measurement averages the fluorescent signal from an area within a single cell (29). Loaded myocytes were stimulated as described above. Measurements from an individual myocyte were taken after a steady state for myocyte contraction was reached following stimulation at 1 Hz. The protocol was completed within 3 h after isolation to avoid any deterioration due to prolonged storage of cells.

Morphological evaluation. Light microscopic observation of isolated myocytes was done to evaluate differences in cell morphology. Freshly isolated myocytes from both alpha -MHC403/+ and WT mice were fixed in 4% paraformaldehyde. An aliquot of cells was washed in PBS with 0.5% Tween 20 and incubated with 10 µg/ml of rhodamine-conjugated phalloidin (Sigma) for 30 min at room temperature. After the cells were stained and washed in PBS, they were mounted and observed with a Leica confocal laser-scanning microscope. Both differential interference contrast and fluorescent images were collected and analyzed using PhotoImage. In addition, two alpha -MHC403/+ and two WT mouse hearts were fixed with 2% phosphate-buffered paraformaldehyde. The LV myocardial samples were embedded in aldehyde epoxy resin. Sections were cut to a 1-µm thickness and stained with toluidine blue. Light microscopic evaluation was used to determine in situ myocyte morphology independent of the perfusion pressure used in isolated myocytes.

RNA extraction and Northern blot analysis. Total RNA was isolated from the left ventricles of WT and alpha -MHC403/+ mice using Trizol (GIBCO BRL) according to the manufacturer's protocol. Total RNA (20 µg) was separated on an agarose-formaldehyde gel and subsequently blotted to a nylon hybridization transfer membrane (GeneScreen Plus, NEN Life Science Products). The oligonucleotides used as transcript-specific probes were as follows: SERCA 5'-AACAACGCACATGCACGCACCCGAACACCCTTATATTTCTGCAAATGG and 5'-GGAACATGTAGACCATGTAGTTGAGGTCAATGAAG. The hybridization signal for SERCA was normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) signal intensity.

Data analysis. LV myocytes from four alpha -MHC403/+ (n = 1,020) and four WT mice (n = 860) were classified morphologically using light microscopy: type I, rod shaped with parallel myofibrils; type II, irregularly shaped, shorter and wider than other types, with parallel myofibrils; and type III, irregularly shaped with disoriented myofibrils. The percentage of myocytes from each type was calculated from each animal, and these data were used for the mean values.

The camera images at 240 samples/s were converted to length measurements by the video edge detector and were analyzed by the data-acquisition system. A combination of five-point median smoothing with a three-point linear smoothing was performed on the data, after which the following contractile properties were calculated from the length data: percent contraction, rate of shortening (-dL/dt), and rate of lengthening (+dL/dt). The smoothing combination was chosen to have minimal effect on the data, the median filtering rid the waveform of any noise spikes, and the linear filtering approximated the transitions between samples of the length of signal. This results in a slight underestimation of the true dL/dt values but has little effect on the relaxation calculations. Therefore, a minimum of three stable beats was analyzed to avoid underestimation during the peak contraction. The contraction slope was calculated from 10 to 90% of full contraction. The time from peak relaxation (+dL/dtmax) to 50% resting length (TR 50%) was also calculated. The time from peak relaxation to 70% resting length (TR 70%) was also calculated, because the length curves during relaxation were biexponential, with a rapid early decay followed by a slower decay.

Measurements from the Ca2+ transients were used to evaluate the peak change in Ca2+ ratio from baseline values. As explained above, three beats were averaged on a temporal basis by aligning the leading edge of each waveform at 50% of peak level, after the data were smoothed with a 21-point Savitsky-Goulet polynomial routine (PTI software). The rate of Ca2+ sequestering during relaxation was characterized by calculating the time to recover from 50 and 70% of peak Ca2+ change (TRC 50% and TRC 70%, respectively). The data for Ca2+ transients could not be separated by type I, II, and III cells because Ca2+ transients were measured through a small window of the myocyte rather than from the whole cells to minimize motion artifacts during contraction.

All data are expressed as means ± SE. Comparisons of the data between WT and mutant mice were performed by Student's t-test for grouped comparison with significant differences taken at P < 0.05. They were performed after the data from all cells studied in each animal were averaged. Because of the heterogeneity of morphology in alpha -MHC403/+ cells, additional statistical analysis was performed on cells that were both longer and shorter compared with wild-type control cells.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

LV myocytes from both alpha -MHC403/+ and wild-type mice were classified morphologically. Compared with WT myocytes, alpha -MHC403+ myocytes showed more irregular cell outlines with apparently more cell junctional areas and less well-aligned myofibrils within the cells but with no change in sarcomere length, which ranged between 1.81 and 1.87 mm (Figs. 1 and 2). Compared with WT hearts, alpha -MHC403/+ hearts had fewer type I cells (WT = 74 ± 3%; alpha -MHC403/+ = 41 ± 4%, P < 0.01) and more type III cells (WT = 12 ± 3%; alpha -MHC403/+ = 49 ± 7%, P < 0.01). The altered morphology was observed in myocytes isolated in both Ca2+-containing (Fig. 1) and Ca2+-free (Fig. 2) solutions. Both myocytes and tissue sections (Fig. 1, C and D) from alpha -MHC403/+ mice showed irregular morphology, i.e., shorter in length and wider than WT, with misaligned myofibrils. Staining with rhodamine-phalloidin for actin filaments and examination by confocal microscopy revealed disorganization of the myofibrils in type III cells (Fig. 2).


View larger version (112K):
[in this window]
[in a new window]
 
Fig. 1.   Morphology of wild-type (WT; a and b) and alpha -myosin heavy chain 403/+ myocytes (alpha -MHC403/+; c and d) showing myofibril disorientation in both alpha -MHC403/+ isolated myocytes (c) and in situ (d). Myocyte and tissue section from alpha -MHC403/+ mice showed irregular morphology, i.e., shorter in length and wider with misaligned myofibrils.



View larger version (102K):
[in this window]
[in a new window]
 
Fig. 2.   Confocal fluorescent (a and c) and differential interference contrast (b and d) images of left ventricular myocytes from WT (a and b) and alpha -MHC403/+ mice (c and d) showing disorganization of myofibrils with more cell junctional areas in alpha -MHC403/+ myocytes.

Indexes of contractile and relaxation function are summarized in Table 1. In alpha -MHC403/+ LV myocytes, diastolic and systolic lengths were significantly less than in WT myocytes (WT = 130 ± 3, alpha -MHC403/+ = 118 ± 3 µm, P < 0.05), but percent contraction was similar (Fig. 3). Both contractile and relaxation properties of alpha -MHC403/+ mice were significantly impaired (P < 0.05) compared with those of WT mice. For example, the rate of contraction (-dL/dtmax), contraction slope, and relaxation times (TR 50% and TR 70%) were altered by 20-25% in the alpha -MHC403/+ myocytes compared with WT myocytes (Table 1 and Fig. 4).

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Contraction and relaxation in male WT and alpha -MHC403/+ myocytes



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   Representative contraction recordings from WT left ventricular myocyte compared with alpha -MHC403/+ myocyte demonstrating that resting length (left) from mutant myocyte is shorter and velocity of shortening and relengthening (dL/dt; right) are also significantly delayed. Numbers in left panel indicate %contraction.



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 4.   Representative contraction (left) and dL/dt (right) recordings from male WT left ventricular myocyte compared with alpha -MHC403/+ myocyte. Calculation for contraction (cont) slope, which was calculated between 10 and 90% contraction, and times to 50% and 70% relaxation (TR 50% and TR 70%) are also shown.

Because there were more type III cells, which were shorter and wider with disoriented myofibrils, in the alpha -MHC403/+, it was important to determine whether this alone could account for the differences in contractile function. Accordingly, we divided the data from the mutant myocytes into those myocytes with less than the mean end-diastolic length (<120 µm) and those with an end-diastolic length >120 µm. The longer cells were predominantly type I, rod-shaped myocytes with parallel myofibrils. Whereas both subgroups of myocytes demonstrated impaired contractile and relaxation function (Table 2), the impairment was greater in shorter cells.

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Effects of cell morphology on contraction and relaxation in male WT and alpha -MHC403/+ myocytes

Changes in Ca2+ concentration during relaxation and contraction. To begin to understand why alpha -MHC403/+-derived LV myocytes had impaired function, Ca2+ concentrations were recorded during the contraction-relaxation cycle of isolated myocytes. The changes in intracellular Ca2+ concentration associated with contraction were estimated by comparing the emission spectra of fura 2 after excitation of loaded myocytes at 340 and 380 nm. The levels of diastolic free Ca2+ concentration and Ca2+ signal during contraction, monitored as the 340/380 ratio, was similar in WT and alpha -MHC403/+ myocytes (Table 3). However, the times required for decay of this signal by 50 and 70% resting lengths (TRC 50% and TRC 70%, respectively) were significantly prolonged (P < 0.001), suggesting an impaired ability to sequester Ca2+ into the sarcoplasmic reticulum during relaxation (Table 3 and Fig. 5).

                              
View this table:
[in this window]
[in a new window]
 
Table 3.   Ca2+ transient in left ventricular myocytes from WT and alpha -MHC403/+ mice



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 5.   Representative Ca2+ transient recordings from male WT left ventricular myocyte compared with alpha -MHC403/+ myocyte. Calculations for recovery of Ca2+ signal to 50 and 70% of peak Ca2+ change (TRC 50% and TRC 70%) are also shown. In mutant myocytes, TRC 50% and TRC 70% were significantly delayed.

Northern blot analysis of SERCA. Expression of SERCA mRNA from WT and alpha -MHC403/+ mice was similar, i.e., no changes in the 28S and 18S bands were observed (Fig. 6). The normalization to GAPDH also demonstrated no differences (WT = 2.01 ± 0.18, alpha -MHC403/+ = 2.13 ± 0.13).


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 6.   Northern blot analysis of total RNA from WT (+/+) and alpha -MHC403/+ (+/403) mice. A: total RNA (20 µg) showing 28S and 18S rRNA bands. B: Northern blot of sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA). C: Northern blot of glyceraldehyde-3-phosphate dehydrogenase (GAPDH).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Understanding the effects of the Arg403 right-arrow Gln missense mutation on myocyte contraction and relaxation is central to understanding how mutations in the cardiac MHC gene cause FHC. In the present study, we demonstrated that many of the myocytes from heterozygous alpha -MHC403/+ mice, which bear the FHC-causing mutation Arg403 right-arrow Gln, are morphologically altered, i.e., shorter and wider with marked misalignment of myofibrils, compared with myocytes from WT mice.

In an earlier study by Maron et al. (23) in 52 patients with hypertrophic cardiomyopathy, cellular disorganization was widely distributed throughout the left ventricle as a hallmark of hypertrophic cardiomyopathy. Recently, Geisterfer-Lowrance et al. (9) generated a mouse model simulation of FHC by introducing an Arg403 right-arrow Gln mutation into the alpha -cardiac MHC gene, which is highly homologous to human beta -cardiac MHC with 92% identity overall. They (9) demonstrated that cardiac dysfunction, i.e., lower cardiac output and abnormal LV relaxation, preceded histopathological changes such as ventricular hypertrophy with fibrosis, indicating that altered mechanical properties caused abnormal cardiac function. In the present study, isolation of single cardiac myocytes, which provides intrinsic myocyte function independent of systemic hemodynamic and neurohormonal effects, revealed that both contraction and relaxation properties of alpha -MHC403/+ myocytes were significantly impaired. Marian et al. (22) recently demonstrated that human myocytes expressing mutant cardiac troponin T (Arg92 right-arrow Gln), known to cause hypertrophic cardiomyopathy in humans, demonstrated impaired contractility.

Interestingly, we noted that many LV alpha -MHC403/+ myocytes were shorter and wider, with marked misalignment of myofibrils, compared with WT myocytes. However, sarcomere lengths were not altered. Not all myopathic myocytes demonstrate these abnormalities, e.g., the myocytes from cardiomyopathic Syrian hamsters are actually longer and wider (14, 15). One possible difference between their results and ours could be due to the amount of Ca2+ in solution. Therefore, to determine whether Ca2+ in the isolation solution was responsible for the alteration of cell morphology, the myocytes in the present study were also isolated in Ca2+-free solution, as shown in Fig. 2. Under these conditions, we confirmed that alpha -MHC403/+ myocytes, which were isolated without Ca2+ in the solution, were also shorter and wider. Another consideration is that the isolation procedures caused the disarray in myocyte architecture. However, isolation procedures were identical for both groups. Furthermore, we also observed disorientation of myofibrils in situ in perfusion-fixed myocardium without myocyte isolation (Fig. 1). Accordingly, the presence or absence of Ca2+ in the isolation solution or the effects of enzymatic myocyte isolation was not responsible for the altered morphology. Another important morphological aspect of the LV alpha -MHC403/+ myocytes is an irregular cell outline with apparently more cell junctional areas (Fig. 1). More importantly, we also noted that many alpha -MHC403/+ myocytes showed less well-aligned myofibrils within the cells, which may be responsible for the primary functional defects.

Because the population of shorter and wider cells was increased in alpha -MHC403/+, it was important to determine whether this alone was responsible for the depressed contractile (-dL/dt) and relaxation function (+dL/dt; TR 50% and TR 70%). When myocytes of similar length, generally characterized by aligned myofibrils, were compared (Table 2), it was found that the alpha -MHC403/+ myocytes also demonstrated impaired contraction and relaxation function, albeit less so than the shorter myocytes. Thus the shorter and wider myocytes with greater misalignment of myofibrils demonstrated more severe expression of the myopathy. We then wanted to determine whether the difference in end-diastolic length resulted in differences in the extent of shortening. When these two variables were correlated, it was found that end-diastolic length correlated significantly with the extent of shortening of myocytes, but there was no correlation with percent contraction of the myocytes (Fig. 7). This indicates that the extent of shortening was preserved regardless of myocyte length in alpha -MHC403/+ mice. However, the rates of contraction and relengthening as well as the times for 50 and 70% recovery were depressed in LV myocytes from alpha -MHC403/+ mice.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 7.   Relationships between diastolic length and extent shortening (left) and %contraction (right) in WT and alpha -MHC403/+ mice. Extent of shortening (y = 0.04x + 0.06, r = 0.60), but not %contraction (y = 0.006x + 3.8, r = 0.02), was correlated with diastolic length, regardless of myocyte length in both WT and alpha -MHC403/+ mice. 403L, longer than the mean end-diastolic length (>120 µm); 403S, shorter than the mean end-diastolic length (<120 µm).

In addition to distinct abnormalities of morphology and mechanical function of alpha -MHC403/+ myocytes, we utilized an indirect measurement of intracellular Ca2+ to understand the underlying mechanism of contractile and relaxation dysfunction. In an earlier study, Sen et al. (25), using the Syrian hamster (Bio 14.6 strain) as a model of the hereditary cardiomyopathy, observed distinct abnormalities of contractile function in cardiomyopathic cells, i.e., decreases in amplitude and velocity of contraction but not in diastolic relaxation velocity. They (25) also noted that mean cytosolic Ca2+ was significantly higher and Ca2+ uptake was significantly increased in cardiomyopathic cells compared with normal control cells, suggesting that abnormal myocardial Ca2+ homeostasis has a possible role in contractile dysfunction. This has been noted by others (14, 15) in hereditary cardiomyopathy. In the present study, we observed delayed sequestration of Ca2+ into the sarcoplasmic reticulum during relaxation, although the levels of diastolic free Ca2+ concentration were similar between WT and alpha -MHC403/+ mice. Several other studies of pressure-overload hypertrophy have identified delayed relaxation in isolated papillary muscles and isolated myocytes using human (11) and various other models such as ferret (12), rat (13, 27), guinea pig (17), and cat (1-3). Furthermore, prior studies also demonstrated that the mechanism responsible for the diastolic dysfunction in pressure-overload hypertrophy involves impaired Ca2+ reuptake due to a decrease in SERCA (4, 5, 17-19, 21). In addition, transgenic mice with cardiac-specific overexpressed phospholamban exhibit decreases in baseline contractile and relaxation function that are associated with decreases in the amplitude of the Ca2+ transient and prolongation of Ca2+ reuptake in isolated myocytes (16). One possibility for the impaired reuptake of Ca2+ with alpha -MHC430/+ mice involved decreased SERCA levels. However, we found no change in message levels of SERCA in alpha -MHC430/+ myocytes compared with those in WT myocytes. Interestingly, prior studies by Sweeney et al. (26) and Lankford et al. (20) demonstrated that replacement of Arg-403 with Gln decreased the rate of transition within the actin-myosin cross-bridge cycle, depressed myosin ATPase activity, and displayed abnormal force-velocity relationships. Thus, although we do not know the exact mechanism for the alteration of Ca2+ reuptake, it is conceivable that the disorientation of myofibrils alters cross-bridge kinetics, which could result in not only contractile but also relaxation dysfunction.

In conclusion, alpha -MHC403/+ myocytes demonstrated impaired contraction and relaxation. The impaired function in alpha -MHC403/+ myocytes may be due, at least in part, to distinct abnormalities of morphology, i.e., marked misalignment of myofibrils. Potentially, these myocytes with abnormal morphology are those that exhibit a more severe phenotype of the Arg403 right-arrow Gln missense mutation. The altered cardiac dysfunction of alpha -MHC403/+ myocytes is directly due to defective myocyte function rather than to secondary changes in global cardiac function and/or loading conditions. Furthermore, alterations in the rate of contraction and relaxation in the face of preserved percent contraction, in combination with preserved ejection fraction (unpublished data), support the concept that the reduced rate of contraction and relaxation in isolated myocytes is an early finding that occurs before decreased global systolic function.


    ACKNOWLEDGEMENTS

This work was supported in part by National Heart, Lung, and Blood Institute Grants HL-59139, HL-37404, and HL-33107. The contributions of the first two authors are equal.


    FOOTNOTES

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Address for reprint requests and other correspondence: S. F. Vatner, Cardiovascular and Pulmonary Research Inst., Allegheny Univ. of the Health Sciences, 320 East North Ave., Pittsburgh, PA 15212 (E-mail: svatner{at}pgh.auhs.edu).

Received 29 January 1998; accepted in final form 18 January 1999.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Bailey, B. A., K. Dipla, S. Li, and S. R. Houser. Cellular basis of contractile derangements of hypertrophied feline ventricular myocytes. J. Mol. Cell. Cardiol. 29: 1823-1835, 1997[Medline].

2.   Bailey, B. A., and S. R. Houser. Calcium transients in feline left ventricular myocytes with hypertrophy induced by slow progressive pressure overload. J. Mol. Cell. Cardiol. 24: 365-375, 1992[Medline].

3.   Bailey, B. A., and S. R. Houser. Sarcoplasmic reticulum-related changes in cytosolic calcium in pressure-overload-induced feline LV hypertrophy. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H2009-H2016, 1993[Abstract/Free Full Text].

4.   Chang, K. C., J. H. Schreur, M. W. Weiner, and S. A. Camacho. Impaired Ca2+ handling is an early manifestation of pressure-overload hypertrophy in rat hearts. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H228-H2234, 1996[Abstract/Free Full Text].

5.   De la Bastie, D., D. Levitsky, L. Rappaport, J. J. Mercadier, F. Marotte, C. Wisnewsky, V. Brovkovich, K. Schwartz, and A. M. Lompre. Function of the sarcoplasmic reticulum and expression of its Ca2+-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat. Circ. Res. 66: 554-564, 1990[Abstract/Free Full Text].

6.   Del Monte, F., A. J. Kaumann, P. A. Poole-Wilson, D. G. Wynne, J. Pepper, and S. E. Harding. Coexistrance of functioning beta 1- and beta 2-adrenoceptors in single myocytes from human ventricle. Circulation 88: 854-863, 1993[Abstract/Free Full Text].

7.   Epstein, N. D., G. M. Cohn, F. Cyran, and L. Fananapazir. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta -myosin heavy chain gene.A 908Leu right-arrow Val mutation and a 403Arg right-arrow Gln mutation. Circulation 86: 345-352, 1992[Abstract/Free Full Text].

8.   Fananapazir, L., and N. D. Epstein. Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta -myosin heavy chain gene mutations. Circulation 89: 22-32, 1994[Abstract/Free Full Text].

9.   Geisterfer-Lowrance, A. A. T., M. Christe, D. A. Conner, J. S. Ingwall, F. J. Schoen, C. E. Seidman, and J. G. Seidman. A mouse model of familial hypertrophic cardiomyopathy. Science 272: 731-734, 1996[Abstract].

10.   Geisterfer-Lowrance, A. A. T., S. Kass, G. Tanigawa, H. P. Vosberg, W. McKenna, C. E. Seidman, and J. G. Seidman. A molecular basis for familial hypertrophic cardiomyopathy: A beta  cardiac myosin heavy chain gene missense mutation. Cell 62: 999-1006, 1990[Medline].

11.   Gwathmey, J. K., and J. P. Morgan. Altered calcium handling in experimental pressure-overload hypertrophy in the ferret. Circ. Res. 57: 836-843, 1985[Abstract/Free Full Text].

12.   Gwathmey, J. K., S. E. Warren, G. M. Briggs, L. Copelas, M. D. Feldman, P. J. Phillips, M. Callahan, F. J. Schoen, W. Grossman, and J. P. Morgan. Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole. J. Clin. Invest. 87: 1023-1031, 1991.

13.   Ito, N., J. Bartunek, K. W. Spitzer, and B. H. Lorell. Effects of the nitric oxide donor sodium nitroprusside on intracellular pH and contraction in hypertrophied myocytes. Circulation 95: 2303-2311, 1997[Abstract/Free Full Text].

14.   Jasmin, G., and L. Proschek. Calcium and myocardial cell injury. An appraisal in the cardiomyopathic hamster. Can. J. Physiol. Pharmacol. 62: 891-898, 1984[Medline].

15.   Jasmin, G., and L. Proschek. Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. I. Progression of heart and skeletal muscle lesions in the UM-X7.1 line. Muscle Nerve 5: 20-25, 1982[Medline].

16.   Kadambi, V. J., S. Ponniah, J. M. Harrer, B. D. Hoit, G. W. Dorn II, R. A. Walsh, and E. G. Kranias. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J. Clin. Invest. 97: 533-539, 1996[Medline].

17.   Kiss, E., N. A. Ball, E. G. Kranias, and R. A. Walsh. Differential changes in cardiac phospholamban and sarcoplasmic reticular Ca2+-ATPase protein levels. Circ. Res. 77: 759-764, 1995[Abstract/Free Full Text].

18.   Komuro, I., M. Kurabayashi, Y. Shibazaki, F. Takaku, and Y. Yasaki. Molecular cloning and characterization of a Ca2+ + Mg2+-dependent adenosine triphosphatase from rat cardiac sarcoplasmic reticulum. Regulation of its expression by pressure overload and developmental stage. J. Clin. Invest. 83: 1102-1108, 1989.

19.   Lamers, J. M. J., and F. T. Stinis. Defective calcium pump in the sarcoplasmic reticulum of the hypertrophied rabbit heart. Life Sci. 24: 2313-2320, 1979[Medline].

20.   Lankford, E. B., N. D. Epstein, L. Fananapazir, and H. L. Sweeney. Abnormal contractile properties of muscle fibers expressing beta -myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J. Clin. Invest. 95: 1409-1414, 1995.

21.   Levitsky, D., D. De la Bastie, K. Schwartz, and A.-M. Lompre. Ca2+-ATPase and function of sarcoplasmic reticulum during cardiac hypertrophy. Am. J. Physiol. Suppl. (Oct.) 261: 23-26, 1991.

22.   Marian, A. J., G. Zhao, Y. Seta, R. Roberts, and Q. Yu. Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility. Circ. Res. 81: 76-85, 1997[Abstract/Free Full Text].

23.   Maron, B. J., T. Anan, and W. Roberts. Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. Circulation 63: 882-894, 1981[Free Full Text].

24.   Schwartz, K., L. Carrier, P. Guicheney, and M. Komajda. Molecular basis of familiar cardioymyopathies. Circulation 91: 532-540, 1995[Free Full Text].

25.   Sen, L., M. O'Neill, J. D. Marsh, and T. W. Smith. Myocyte structure, function, and calcium kinetics in the cardiomyopathic hamster heart. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H1533-H1543, 1990[Abstract/Free Full Text].

26.   Sweeney, H. L., A. J. Straceski, L. A. Leinwand, B. A. Tikunov, and L. Faust. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J. Biol. Chem. 269: 1603-1605, 1994[Abstract/Free Full Text].

27.   Tsutsui, H., Y. Ishibashi, K. Imanaka-Yoshida, S. Yamamoto, T. Yoshida, M. Sugimachi, Y. Urabe, and A. Takeshita. Alterations in sarcoplasmic reticulum calcium-storing proteins in pressure-overload cardiac hypertrophy. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H168-H175, 1997[Abstract/Free Full Text].

28.   Watkins, H., J. G. Seidman, and C. E. Seidman. Familiar hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy. Hum. Mol. Genet. 4: 1721-1727, 1995[Abstract].

29.   Williford, D. J., V. K. Sharma, M. Korth, and S. Shen. Spatial heterogeneity of intracellular Ca2+ concentration in nonbeating guinea pig ventricular myocytes. Circ. Res. 66: 234-241, 1990[Abstract/Free Full Text].


Am J Physiol Heart Circ Physiol 276(5):H1780-H1787
0002-9513/99 $5.00 Copyright © 1999 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. M. Palmer, Y. Wang, P. Teekakirikul, J. T. Hinson, D. Fatkin, S. Strouse, P. VanBuren, C. E. Seidman, J. G. Seidman, and D. W. Maughan
Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1939 - H1947.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. M. Palmer, D. E. Fishbaugher, J. P. Schmitt, Y. Wang, N. R. Alpert, C. E. Seidman, J. G. Seidman, P. VanBuren, and D. W. Maughan
Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium
Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H91 - H99.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. C. Olsson, B. M. Palmer, B. L. Stauffer, L. A. Leinwand, and R. L. Moore
Morphological and Functional Alterations in Ventricular Myocytes From Male Transgenic Mice With Hypertrophic Cardiomyopathy
Circ. Res., February 6, 2004; 94(2): 201 - 207.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. J. Heller, D. E. Mohrman, J. A. Smith, and K. B. Wallace
Multitrack system for superfusing isolated cardiac myocytes
Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1872 - H1878.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. Fatkin and R. M. Graham
Molecular Mechanisms of Inherited Cardiomyopathies
Physiol Rev, October 1, 2002; 82(4): 945 - 980.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. E. Hardt, Y.-J. Geng, O. Montagne, K. Asai, C. Hong, G. P. Yang, S. P. Bishop, S.-J. Kim, D. E. Vatner, C. E. Seidman, et al.
Accelerated Cardiomyopathy in Mice With Overexpression of Cardiac Gs{alpha} and a Missense Mutation in the {alpha}-Myosin Heavy Chain
Circulation, February 5, 2002; 105(5): 614 - 620.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S.-J. Kim, Y.-K. Kim, G. Takagi, C.-H. Huang, Y.-J. Geng, and S. F. Vatner
Enhanced iNOS function in myocytes one day after brief ischemic episode
Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H423 - H428.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. F. Nagueh, H. A. Kopelen, D.-S. Lim, W. A. Zoghbi, M. A. Quinones, R. Roberts, and A. J. Marian
Tissue Doppler Imaging Consistently Detects Myocardial Contraction and Relaxation Abnormalities, Irrespective of Cardiac Hypertrophy, in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy
Circulation, September 19, 2000; 102(12): 1346 - 1350.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, S.-J.
Right arrow Articles by Vatner, S. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, S.-J.
Right arrow Articles by Vatner, S. F.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online